U.S. patent application number 13/243736 was filed with the patent office on 2012-06-21 for bipolar off-wall electrode device for renal nerve ablation.
Invention is credited to Mark L. Jenson, Scott Smith.
Application Number | 20120157993 13/243736 |
Document ID | / |
Family ID | 46235338 |
Filed Date | 2012-06-21 |
United States Patent
Application |
20120157993 |
Kind Code |
A1 |
Jenson; Mark L. ; et
al. |
June 21, 2012 |
Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
Abstract
A first spacing structure is provided at a distal end of a first
catheter. The first spacing structure is configured to position at
least one arterial electrode at a predefined distance away from a
wall of the renal artery. A second spacing structure is provided at
the distal end of the first catheter or at a distal end of a second
catheter. The second spacing structure is configured to position at
least one aortal electrode at a predefined distance away from a
wall of the aorta. The arterial and aortal electrodes are operable
as a bipolar electrode arrangement. The first and second spacing
structures respectively maintain the arterial and aortal electrodes
at a predefined distance away from the renal artery and aortal
walls while electrical energy sufficient to ablate perivascular
nerve tissue adjacent the renal artery and aortal walls is
delivered by the bipolar electrode arrangement.
Inventors: |
Jenson; Mark L.;
(Greenfield, MN) ; Smith; Scott; (Chaska,
MN) |
Family ID: |
46235338 |
Appl. No.: |
13/243736 |
Filed: |
September 23, 2011 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
61423439 |
Dec 15, 2010 |
|
|
|
61434136 |
Jan 19, 2011 |
|
|
|
61503378 |
Jun 30, 2011 |
|
|
|
61503382 |
Jun 30, 2011 |
|
|
|
61503386 |
Jun 30, 2011 |
|
|
|
Current U.S.
Class: |
606/41 |
Current CPC
Class: |
A61B 2018/00875
20130101; A61B 18/1492 20130101; A61B 2018/00434 20130101; A61B
2018/00821 20130101; A61B 2018/00577 20130101; A61B 2018/00267
20130101 |
Class at
Publication: |
606/41 |
International
Class: |
A61B 18/16 20060101
A61B018/16 |
Claims
1. An apparatus, comprising: a first catheter having a proximal end
and a distal end; a first spacing structure provided at the distal
end of the first catheter, the first spacing structure configured
for deployment in a patient's renal artery and to position at least
one arterial electrode at a predefined distance away from a wall of
the renal artery; a second spacing structure provided at the distal
end of the first catheter or at a distal end of a second catheter,
the second spacing structure configured for deployment in the
patient's aorta proximate the renal artery and to position at least
one aortal electrode at a predefined distance away from a wall of
the aorta; the at least one arterial and aortal electrodes operable
as a bipolar electrode arrangement; and each of the first and
second spacing structures respectively maintaining the at least one
arterial and aortal electrodes at a predefined distance away from
the renal artery and aortal walls while electrical energy
sufficient to ablate perivascular nerve tissue adjacent the renal
artery and aortal walls is delivered by the bipolar electrode
arrangement.
2. The apparatus of claim 1, wherein the first and second spacing
structures comprise one or more electrically nonconductive spacers
which extend outwardly farther than the at least one arterial and
aortal electrodes.
3. The apparatus of claim 1, wherein the first and second spacing
structures comprise one or more electrically nonconductive spheres
having a diameter greater than that of the at least one arterial
and aortal electrodes.
4. The apparatus of claim 1, wherein the first and second spacing
structures comprise one or more electrically nonconductive bumps,
curves, struts, or baskets.
5. The apparatus of claim 1, wherein the first and second spacing
structures are respectively supported by a common catheter.
6. The apparatus of claim 1, wherein one of the first and second
spacing structures is supported by a first catheter or sheath, and
the other of the first and second spacing structures is supported
by a second catheter or sheath.
7. The apparatus of claim 1, wherein each of the at least one
arterial electrodes is coupled to a separate electrical conductor
extending along the first catheter.
8. The apparatus of claim 1, wherein each of the at least one
arterial and aortal electrodes is coupled to a separate conductor
extending along the first catheter so that the at least one
arterial and aortal electrodes can be energized independently.
9. The apparatus of claim 1, wherein at least the first spacing
structure comprises a helical wire.
10. The apparatus of claim 1, wherein: the first spacing structure
comprises a helical wire having a first diameter in its deployed
configuration; the second spacing structure comprise a helical wire
having a second diameter in its deployed configuration; and the
second diameter is greater than the first diameter.
11. The apparatus of claim 1, comprising a sheath dimensioned to
receive the apparatus in a non-deployed configuration, the sheath
configured to transport a fluid for delivery to the renal
artery.
12. The apparatus of claim 1, wherein one or both of the first and
second spacing structures comprises a shape-memory member or a
superelastic member.
13. The apparatus of claim 1, comprising an external control unit
electrically coupled to each of the at least one arterial and
aortal electrodes and configured to supply energy to each of the at
least one arterial and aortal electrodes in accordance with one or
more predetermined activation patterns or sequences.
14. The apparatus of claim 13, wherein the external control unit is
configured to monitor tissue impedance between selected pairs of
the at least one arterial and aortal electrodes.
15. An apparatus, comprising: a first catheter having a proximal
end and a distal end; a first spacing structure provided at the
distal end of the first catheter, the first spacing structure
configured for deployment in a body vessel, chamber, cavity, organ,
or tissue structure and to position at least one electrode at a
predefined distance away from the body vessel, chamber, cavity,
organ, or tissue structure; a second spacing structure provided at
the distal end of the first catheter or at a distal end of a second
catheter, the second spacing structure configured to support at
least one electrode and for deployment at a body location spaced
apart from the at least one electrode of the first spacing
structure; the respective at least one electrodes operable as a
bipolar electrode arrangement; and at least the first spacing
structure maintaining the at least one electrode at the predefined
distance away from the body vessel, chamber, cavity, organ, or
tissue structure while electrical energy sufficient to ablate
target tissue adjacent the body vessel, chamber, cavity, organ, or
tissue structure is delivered by the bipolar electrode
arrangement.
16. The apparatus of claim 15, wherein each of the first and second
spacing structures is configured to respectively maintain the at
least one electrode at a predefined distance away from the body
vessel, chamber, cavity, organ, or tissue structure while
electrical energy sufficient to ablate the target tissue is
delivered by the bipolar electrode arrangement.
17. The apparatus of claim 15, wherein the first and second spacing
structures comprise one or more electrically nonconductive spacers
which extend outwardly farther than the at least one electrodes,
respectively.
18. The apparatus of claim 15, comprising an external control unit
electrically coupled to each of the at least one electrodes and
configured to supply energy to each of the at least one electrodes
in accordance with one or more predetermined activation patterns or
sequences.
19. The apparatus of claim 15, wherein one or both of the first and
second spacing structures comprises a shape-memory member or a
superelastic member.
20. A method, comprising: causing a first support structure
situated within or at a body vessel, chamber, cavity, organ, or
tissue structure to transform between a low-profile introduction
configuration and a larger-profile deployed configuration;
maintaining space between an electrode arrangement and the body
vessel, chamber, cavity, organ, or tissue structure using the first
support structure in the deployed configuration; ablating target
tissue adjacent the body vessel, chamber, cavity, organ, or tissue
structure using the electrode arrangement and another electrode
arrangement spaced apart from the electrode arrangement while the
first support structure is in the deployed configuration; and
causing the first support structure to transform from the
larger-profile deployed configuration to the low-profile
introduction configuration after ablating the target tissue.
21. The method of claim 20, comprising: causing a second support
structure situated within or at a body vessel, chamber, cavity,
organ, or tissue structure to transform between a low-profile
introduction configuration and a larger-profile deployed
configuration; maintaining space between the other electrode
arrangement and the body vessel, chamber, cavity, organ, or tissue
structure using the second support structure in the deployed
configuration; ablating target tissue adjacent the body vessel,
chamber, cavity, organ, or tissue structure using the respective
electrode arrangements while the first and second support
structures are in the deployed configuration; and causing the first
and second support structures to transform from the larger-profile
deployed configuration to the low-profile introduction
configuration after ablating the target tissue.
Description
RELATED PATENT DOCUMENTS
[0001] This application claims the benefit of Provisional Patent
Application Ser. Nos. 61/423,439 filed Dec. 15, 2010; 61/434,136
filed Jan. 19, 2011; 61/503,378 filed Jun. 30, 2011; 61/503,382
filed Jun. 30, 2011; 61/503,386 filed Jun. 30, 2011; and to which
priority is claimed pursuant to 35 U.S.C..sctn.119(e) and which are
hereby incorporated herein by reference.
SUMMARY
[0002] Devices, systems, and methods of the disclosure are directed
to ablating target tissue of the body using a bipolar electrode
arrangement that positions electrodes a distance away from body
tissue during ablation of the target tissue. Devices, systems, and
methods of the disclosure are directed to ablating target tissue
adjacent a body vessel, chamber, cavity, or tissue structure using
a bipolar electrode arrangement that positions electrodes a
distance away from the body vessel, chamber, cavity, or tissue
structure during ablation of the target tissue. Devices, systems,
and methods are directed to denervating tissues that contribute to
renal sympathetic nerve activity, such as perivascular renal
nerves, using high frequency alternating current delivered to
bipolar electrodes positioned a distance away from the inner wall
of a renal artery during ablation.
[0003] Various embodiments of the disclosure are directed to
ablation apparatuses and methods of ablation that include or use a
positioning apparatus to maintain a gap between electrodes of a
bipolar electrode arrangement and tissue of the body. The
positioning apparatus is preferably configured to maintain
positioning of electrodes a short distance away from body tissue
during an ablation procedure. Although described in the context of
ablation procedures performed from within a vessel hereinbelow, it
is understood that positioning apparatuses consistent with the
present disclosure may be implemented to maintain a gap between
electrodes configured for RF bipolar ablation and a body vessel,
chamber, cavity, or tissue structure (e.g., organ) during
ablation.
[0004] In some embodiments, at least one electrode structure of a
bipolar electrode arrangement includes a spacing structure
configured to contact a body vessel, chamber, cavity, or tissue
structure while holding one or more electrodes a distance away from
the body vessel, chamber, cavity, or tissue structure during
ablation. The other electrode structure of the bipolar electrode
arrangement can include or exclude a spacing structure configured
to contact a body vessel, chamber, cavity, or tissue structure
while holding one or more electrodes a distance away from the body
vessel, chamber, cavity, or tissue structure during ablation. The
various electrodes can be of the same or a different type (e.g.,
same or different in terms of size, materials, number, or other
physical, electrical, or mechanical attributes).
[0005] Various embodiments are directed to apparatuses which
include a first catheter having a proximal end and a distal end,
and a first spacing structure provided at the distal end of the
first catheter. The first spacing structure is configured for
deployment in a body vessel, chamber, cavity, organ, or tissue
structure and to position at least one electrode at a predefined
distance away from the body vessel, chamber, cavity, organ, or
tissue structure. A second spacing structure is provided at the
distal end of the first catheter or at a distal end of a second
catheter. The second spacing structure is configured to support at
least one electrode and for deployment at a body location spaced
apart from the at least one electrode of the first spacing
structure. The electrodes are operable as a bipolar electrode
arrangement. At least the first spacing structure is configured to
maintain the electrode at the predefined distance away from the
body vessel, chamber, cavity, organ, or tissue structure while
electrical energy sufficient to ablate target tissue adjacent the
body vessel, chamber, cavity, organ, or tissue structure is
delivered by the bipolar electrode arrangement. In some
embodiments, each of the first and second spacing structures is
configured to respectively maintain the electrodes at a predefined
distance away from the body vessel, chamber, cavity, organ, or
tissue structure while electrical energy sufficient to ablate the
target tissue is delivered by the bipolar electrode
arrangement.
[0006] According to other embodiments, an ablation apparatus
includes a first catheter having a proximal end and a distal end,
and a first spacing structure provided at the distal end of the
first catheter. The first spacing structure is configured for
deployment in a patient's renal artery and to position at least one
arterial electrode at a predefined distance away from a wall of the
renal artery. A second spacing structure is provided at the distal
end of the first catheter or at a distal end of a second catheter.
The second spacing structure is configured for deployment in the
patient's aorta proximate the renal artery and to position at least
one aortal electrode at a predefined distance away from a wall of
the aorta. The arterial and aortal electrodes are operable as a
bipolar electrode arrangement. Each of the first and second spacing
structures are configured to respectively maintain the arterial and
aortal electrodes at a predefined distance away from the renal
artery and aortal walls while electrical energy sufficient to
ablate perivascular nerve tissue adjacent the renal artery and
aortal walls is delivered by the bipolar electrode arrangement.
[0007] Further embodiments are directed to methods involving
causing a first support structure situated within or at a body
vessel, chamber, cavity, organ, or tissue structure to transform
between a low-profile introduction configuration and a
larger-profile deployed configuration, and maintaining space
between an ablation electrode arrangement and the body vessel,
chamber, cavity, organ, or tissue structure using the first support
structure in the deployed configuration. Methods also involve
ablating target tissue adjacent the body vessel, chamber, cavity,
organ, or tissue structure using an electrode arrangement and a
another electrode arrangement spaced apart from the electrode
arrangement while the first support structure is in the deployed
configuration, and causing the first support structure to transform
from the larger-profile deployed configuration to the low-profile
introduction configuration after ablating the target tissue.
[0008] According to some embodiments, methods involve causing a
second support structure situated within or at a body vessel,
chamber, cavity, organ, or tissue structure to transform between a
low-profile introduction configuration and a larger-profile
deployed configuration, and maintaining space between the electrode
arrangement and the body vessel, chamber, cavity, organ, or tissue
structure using the second support structure in the deployed
configuration. Methods further involve ablating target tissue
adjacent the body vessel, chamber, cavity, organ, or tissue
structure using the electrode arrangements while the first and
second support structures are in the deployed configuration, and
causing the first and second support structures to transform from
the larger-profile deployed configuration to the low-profile
introduction configuration after ablating the target tissue.
[0009] These and other features can be understood in view of the
following detailed discussion and the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
[0010] FIG. 1 is an illustration of a right kidney and renal
vasculature including a renal artery branching laterally from the
abdominal aorta;
[0011] FIGS. 2A and 2B illustrate sympathetic innervation of the
renal artery;
[0012] FIG. 3A illustrates various tissue layers of the wall of the
renal artery;
[0013] FIGS. 3B and 3C illustrate a portion of a renal nerve;
[0014] FIG. 4 illustrates computer modeling of heat distribution
through a vessel wall generated by an RF electrode placed in
contact with the inner wall of the vessel;
[0015] FIG. 5 illustrates computer modeling of heat distribution
through the same vessel wall generated by an RF electrode placed in
a non-contacting relationship with the inner wall of the vessel in
accordance with various embodiments;
[0016] FIG. 6 shows a bipolar off-wall RF electrode arrangement
deployed in a patient's renal artery and in the patient's aorta in
accordance with various embodiments;
[0017] FIG. 7 shows a bipolar off-wall RF electrode arrangement
deployed in each of a patient's renal arteries in accordance with
various embodiments;
[0018] FIGS. 8 and 9 show a bipolar off-wall RF electrode
arrangement deployed in a patient's renal artery and in the
patient's aorta in accordance with various embodiments;
[0019] FIG. 10 shows an off-wall RF electrode arrangement of an
ablation catheter in a relatively collapsed configuration within an
external sheath or guide catheter in accordance with various
embodiments;
[0020] FIG. 11 illustrates a first off-wall electrode arrangement
of an ablation catheter expanded and deployed in a renal artery,
and a second off-wall electrode arrangement in a relatively
collapsed configuration within an external sheath or guide catheter
in accordance with various embodiments;
[0021] FIG. 12 shows a bipolar off-wall RF electrode arrangement
deployed in each of a patient's renal arteries in accordance with
various embodiments;
[0022] FIG. 13A shows an off-wall RF electrode arrangement of an
ablation catheter in a collapsed configuration in accordance with
various embodiments;
[0023] FIG. 13B shows the off-wall RF electrode arrangement of FIG.
13A in an expanded configuration in accordance with various
embodiments;
[0024] FIG. 14 shows a bipolar off-wall RF electrode arrangement
deployed in each of a patient's renal arteries in a collapsed
configuration in accordance with various embodiments;
[0025] FIG. 15 shows a unipolar off-wall RF electrode arrangement
positioned in a patient's renal artery and in an expanded
configuration in accordance with various embodiments;
[0026] FIG. 16A shows a unipolar off-wall RF electrode arrangement
of an ablation catheter in a collapsed configuration in accordance
with various embodiments;
[0027] FIG. 16B shows the unipolar off-wall RF electrode
arrangement of FIG. 16A in an expanded configuration in accordance
with various embodiments;
[0028] FIG. 17 shows a unipolar off-wall RF electrode arrangement
positioned in a patient's renal artery and in a collapsed
configuration in accordance with various embodiments;
[0029] FIG. 18 shows the unipolar off-wall RF electrode arrangement
of FIG. 17 in an expanded configuration in accordance with various
embodiments;
[0030] FIG. 19 shows a representative RF renal therapy apparatus in
accordance with various embodiments;
[0031] FIG. 20 shows an off-wall RF electrode arrangement biased
against a side of the inner wall of the renal artery in accordance
with various embodiments; and
[0032] FIG. 21 shows an embodiment of an off-wall spacing
arrangement and an ultrasound ablation device encompassed by the
off-wall spacing arrangement in accordance with various
embodiments.
DESCRIPTION
[0033] Embodiments of the disclosure are directed to apparatuses
and methods for ablating target tissue of the body. Embodiments of
the disclosure are directed to apparatuses and methods for ablating
perivascular renal nerves for the treatment of hypertension.
Embodiments of the disclosure are directed to bipolar RF electrode
arrangements configured to maintain positioning of electrodes in a
space-apart relationship relative to an inner wall of a vessel
during renal nerve ablation.
[0034] Ablation of perivascular renal nerves has been used as a
treatment for hypertension. The autonomic nervous system includes
afferent and efferent nerves connecting the kidneys to the central
nervous system. At least some of these nerves travel in a
perivascular location along the renal arteries. The exact locations
of these nerves can be difficult to determine, but there is
typically one or more ganglia just outside the aorta, near the
junction with the renal artery, and nerves running along the renal
arteries, with one or more additional ganglia. The ganglia are
variable in number, size, and position, and can be located at the
aortorenal junction, or around towards the anterior aspect of the
aorta, or farther down along the renal artery, and can be on any
side of the renal artery.
[0035] Conventional treatment approaches typically use monopolar
radiofrequency (RF) electrodes placed in the renal artery to ablate
the perivascular nerves, but with risk of artery wall injury. To
control injury to the artery wall, one approach is to ablate at
discrete locations along and around the artery, which simply limits
the arterial injury to multiple smaller locations. With this
approach, high current density typically occurs in the tissue
closest to the electrode contact region, causing preferential
heating and injury to the artery wall at each of the discrete
locations. Multiple discrete ablations also extend the procedure
time.
[0036] Due to the limitations of artery wall heating, previous
approaches cannot treat certain patients, such as those with short
or multiple renal arteries. Also, previous approaches require
larger electrodes to reduce current density and improve heat
transfer for artery wall cooling. In some situations, a
lower-profile device may be desired, to reduce vascular
complications or to facilitate radial artery access. A better
approach to ablating renal sympathetic nerves for treatment of
hypertension is needed, especially targeting the renal ganglia and
further reducing arterial injury, preferably with lower profile
devices.
[0037] Embodiments of the disclosure are directed to apparatuses
and methods for RF ablation of renal autonomic ganglia and nerves
for the treatment of hypertension with reduced renal artery injury.
Various embodiments of the disclosure employ a bipolar off-wall RF
electrode configuration to more effectively ablate nerves and
ganglia near the renal ostium, without renal artery injury. Some
embodiments employ a unipolar off-wall RF electrode configuration
to more effectively ablate renal nerves and ganglia without renal
artery injury.
[0038] Various embodiments of the disclosure are directed to
apparatuses and methods for renal denervation for treating
hypertension. Hypertension is a chronic medical condition in which
the blood pressure is elevated. Persistent hypertension is a
significant risk factor associated with a variety of adverse
medical conditions, including heart attacks, heart failure,
arterial aneurysms, and strokes. Persistent hypertension is a
leading cause of chronic renal failure. Hyperactivity of the
sympathetic nervous system serving the kidneys is associated with
hypertension and its progression. Deactivation of nerves in the
kidneys via renal denervation can reduce blood pressure, and may be
a viable treatment option for many patients with hypertension who
do not respond to conventional drugs.
[0039] The kidneys are instrumental in a number of body processes,
including blood filtration, regulation of fluid balance, blood
pressure control, electrolyte balance, and hormone production. One
primary function of the kidneys is to remove toxins, mineral salts,
and water from the blood to form urine. The kidneys receive about
20-25% of cardiac output through the renal arteries that branch
left and right from the abdominal aorta, entering each kidney at
the concave surface of the kidneys, the renal hilum.
[0040] Blood flows into the kidneys through the renal artery and
the afferent arteriole, entering the filtration portion of the
kidney, the renal corpuscle. The renal corpuscle is composed of the
glomerulus, a thicket of capillaries, surrounded by a fluid-filled,
cup-like sac called Bowman's capsule. Solutes in the blood are
filtered through the very thin capillary walls of the glomerulus
due to the pressure gradient that exists between the blood in the
capillaries and the fluid in the Bowman's capsule. The pressure
gradient is controlled by the contraction or dilation of the
arterioles. After filtration occurs, the filtered blood moves
through the efferent arteriole and the peritubular capillaries,
converging in the interlobular veins, and finally exiting the
kidney through the renal vein.
[0041] Particles and fluid filtered from the blood move from the
Bowman's capsule through a number of tubules to a collecting duct.
Urine is formed in the collecting duct and then exits through the
ureter and bladder. The tubules are surrounded by the peritubular
capillaries (containing the filtered blood). As the filtrate moves
through the tubules and toward the collecting duct, nutrients,
water, and electrolytes, such as sodium and chloride, are
reabsorbed into the blood.
[0042] The kidneys are innervated by the renal plexus which
emanates primarily from the aorticorenal ganglion. Renal ganglia
are formed by the nerves of the renal plexus as the nerves follow
along the course of the renal artery and into the kidney. The renal
nerves are part of the autonomic nervous system which includes
sympathetic and parasympathetic components. The sympathetic nervous
system is known to be the system that provides the bodies "fight or
flight" response, whereas the parasympathetic nervous system
provides the "rest and digest" response. Stimulation of sympathetic
nerve activity triggers the sympathetic response which causes the
kidneys to increase production of hormones that increase
vasoconstriction and fluid retention. This process is referred to
as the renin-angiotensin-aldosterone-system (RAAS) response to
increased renal sympathetic nerve activity.
[0043] In response to a reduction in blood volume, the kidneys
secrete renin, which stimulates the production of angiotensin.
Angiotensin causes blood vessels to constrict, resulting in
increased blood pressure, and also stimulates the secretion of the
hormone aldosterone from the adrenal cortex. Aldosterone causes the
tubules of the kidneys to increase the reabsorption of sodium and
water, which increases the volume of fluid in the body and blood
pressure.
[0044] Congestive heart failure (CHF) is a condition that has been
linked to kidney function. CHF occurs when the heart is unable to
pump blood effectively throughout the body. When blood flow drops,
renal function degrades because of insufficient perfusion of the
blood within the renal corpuscles. The decreased blood flow to the
kidneys triggers an increase in sympathetic nervous system activity
(i.e., the RAAS becomes too active) that causes the kidneys to
secrete hormones that increase fluid retention and vasorestriction.
Fluid retention and vasorestriction in turn increases the
peripheral resistance of the circulatory system, placing an even
greater load on the heart, which diminishes blood flow further. If
the deterioration in cardiac and renal functioning continues,
eventually the body becomes overwhelmed, and an episode of heart
failure decompensation occurs, often leading to hospitalization of
the patient.
[0045] FIG. 1 is an illustration of a right kidney 10 and renal
vasculature including a renal artery 12 branching laterally from
the abdominal aorta 20. In FIG. 1, only the right kidney 10 is
shown for purposes of simplicity of explanation, but reference will
be made herein to both right and left kidneys and associated renal
vasculature and nervous system structures, all of which are
contemplated within the context of embodiments of the disclosure.
The renal artery 12 is purposefully shown to be disproportionately
larger than the right kidney 10 and abdominal aorta 20 in order to
facilitate discussion of various features and embodiments of the
present disclosure.
[0046] The right and left kidneys are supplied with blood from the
right and left renal arteries that branch from respective right and
left lateral surfaces of the abdominal aorta 20. Each of the right
and left renal arteries is directed across the crus of the
diaphragm, so as to form nearly a right angle with the abdominal
aorta 20. The right and left renal arteries extend generally from
the abdominal aorta 20 to respective renal sinuses proximate the
hilum 17 of the kidneys, and branch into segmental arteries and
then interlobular arteries within the kidney 10. The interlobular
arteries radiate outward, penetrating the renal capsule and
extending through the renal columns between the renal pyramids.
Typically, the kidneys receive about 20% of total cardiac output
which, for normal persons, represents about 1200 mL of blood flow
through the kidneys per minute.
[0047] The primary function of the kidneys is to maintain water and
electrolyte balance for the body by controlling the production and
concentration of urine. In producing urine, the kidneys excrete
wastes such as urea and ammonium. The kidneys also control
reabsorption of glucose and amino acids, and are important in the
production of hormones including vitamin D, renin and
erythropoietin.
[0048] An important secondary function of the kidneys is to control
metabolic homeostasis of the body. Controlling hemostatic functions
include regulating electrolytes, acid-base balance, and blood
pressure. For example, the kidneys are responsible for regulating
blood volume and pressure by adjusting volume of water lost in the
urine and releasing erythropoietin and renin, for example. The
kidneys also regulate plasma ion concentrations (e.g., sodium,
potassium, chloride ions, and calcium ion levels) by controlling
the quantities lost in the urine and the synthesis of calcitrol.
Other hemostatic functions controlled by the kidneys include
stabilizing blood pH by controlling loss of hydrogen and
bicarbonate ions in the urine, conserving valuable nutrients by
preventing their excretion, and assisting the liver with
detoxification.
[0049] Also shown in FIG. 1 is the right suprarenal gland 11,
commonly referred to as the right adrenal gland. The suprarenal
gland 11 is a star-shaped endocrine gland that rests on top of the
kidney 10. The primary function of the suprarenal glands (left and
right) is to regulate the stress response of the body through the
synthesis of corticosteroids and catecholamines, including cortisol
and adrenaline (epinephrine), respectively. Encompassing the
kidneys 10, suprarenal glands 11, renal vessels 12, and adjacent
perirenal fat is the renal fascia, e.g., Gerota's fascia, (not
shown), which is a fascial pouch derived from extraperitoneal
connective tissue.
[0050] The autonomic nervous system of the body controls
involuntary actions of the smooth muscles in blood vessels, the
digestive system, heart, and glands. The autonomic nervous system
is divided into the sympathetic nervous system and the
parasympathetic nervous system. In general terms, the
parasympathetic nervous system prepares the body for rest by
lowering heart rate, lowering blood pressure, and stimulating
digestion. The sympathetic nervous system effectuates the body's
fight-or-flight response by increasing heart rate, increasing blood
pressure, and increasing metabolism.
[0051] In the autonomic nervous system, fibers originating from the
central nervous system and extending to the various ganglia are
referred to as preganglionic fibers, while those extending from the
ganglia to the effector organ are referred to as postganglionic
fibers. Activation of the sympathetic nervous system is effected
through the release of adrenaline (epinephrine) and to a lesser
extent norepinephrine from the suprarenal glands 11. This release
of adrenaline is triggered by the neurotransmitter acetylcholine
released from preganglionic sympathetic nerves.
[0052] The kidneys and ureters (not shown) are innervated by the
renal nerves 14. FIGS. 1 and 2A-2B illustrate sympathetic
innervation of the renal vasculature, primarily innervation of the
renal artery 12. The primary functions of sympathetic innervation
of the renal vasculature include regulation of renal blood flow and
pressure, stimulation of renin release, and direct stimulation of
water and sodium ion reabsorption.
[0053] Most of the nerves innervating the renal vasculature are
sympathetic postganglionic fibers arising from the superior
mesenteric ganglion 26. The renal nerves 14 extend generally
axially along the renal arteries 12, enter the kidneys 10 at the
hilum 17, follow the branches of the renal arteries 12 within the
kidney 10, and extend to individual nephrons. Other renal ganglia,
such as the renal ganglia 24, superior mesenteric ganglion 26, the
left and right aorticorenal ganglia 22, and celiac ganglia 28 also
innervate the renal vasculature. The celiac ganglion 28 is joined
by the greater thoracic splanchnic nerve (greater TSN). The
aorticorenal ganglia 26 is joined by the lesser thoracic splanchnic
nerve (lesser TSN) and innervates the greater part of the renal
plexus.
[0054] Sympathetic signals to the kidney 10 are communicated via
innervated renal vasculature that originates primarily at spinal
segments T10-T12 and L1. Parasympathetic signals originate
primarily at spinal segments S2-S4 and from the medulla oblongata
of the lower brain. Sympathetic nerve traffic travels through the
sympathetic trunk ganglia, where some may synapse, while others
synapse at the aorticorenal ganglion 22 (via the lesser thoracic
splanchnic nerve, i.e., lesser TSN) and the renal ganglion 24 (via
the least thoracic splanchnic nerve, i.e., least TSN). The
postsynaptic sympathetic signals then travel along nerves 14 of the
renal artery 12 to the kidney 10. Presynaptic parasympathetic
signals travel to sites near the kidney 10 before they synapse on
or near the kidney 10.
[0055] With particular reference to FIG. 2A, the renal artery 12,
as with most arteries and arterioles, is lined with smooth muscle
34 that controls the diameter of the renal artery lumen 13. Smooth
muscle, in general, is an involuntary non-striated muscle found
within the media layer of large and small arteries and veins, as
well as various organs. The glomeruli of the kidneys, for example,
contain a smooth muscle-like cell called the mesangial cell. Smooth
muscle is fundamentally different from skeletal muscle and cardiac
muscle in terms of structure, function, excitation-contraction
coupling, and mechanism of contraction.
[0056] Smooth muscle cells can be stimulated to contract or relax
by the autonomic nervous system, but can also react on stimuli from
neighboring cells and in response to hormones and blood borne
electrolytes and agents (e.g., vasodilators or vasoconstrictors).
Specialized smooth muscle cells within the afferent arteriole of
the juxtaglomerular apparatus of kidney 10, for example, produces
renin which activates the angiotension II system.
[0057] The renal nerves 14 innervate the smooth muscle 34 of the
renal artery wall 15 and extend lengthwise in a generally axial or
longitudinal manner along the renal artery wall 15. The smooth
muscle 34 surrounds the renal artery circumferentially, and extends
lengthwise in a direction generally transverse to the longitudinal
orientation of the renal nerves 14, as is depicted in FIG. 2B.
[0058] The smooth muscle 34 of the renal artery 12 is under
involuntary control of the autonomic nervous system. An increase in
sympathetic activity, for example, tends to contract the smooth
muscle 34, which reduces the diameter of the renal artery lumen 13
and decreases blood perfusion. A decrease in sympathetic activity
tends to cause the smooth muscle 34 to relax, resulting in vessel
dilation and an increase in the renal artery lumen diameter and
blood perfusion. Conversely, increased parasympathetic activity
tends to relax the smooth muscle 34, while decreased
parasympathetic activity tends to cause smooth muscle
contraction.
[0059] FIG. 3A shows a segment of a longitudinal cross-section
through a renal artery, and illustrates various tissue layers of
the wall 15 of the renal artery 12. The innermost layer of the
renal artery 12 is the endothelium 30, which is the innermost layer
of the intima 32 and is supported by an internal elastic membrane.
The endothelium 30 is a single layer of cells that contacts the
blood flowing though the vessel lumen 13. Endothelium cells are
typically polygonal, oval, or fusiform, and have very distinct
round or oval nuclei. Cells of the endothelium 30 are involved in
several vascular functions, including control of blood pressure by
way of vasoconstriction and vasodilation, blood clotting, and
acting as a barrier layer between contents within the lumen 13 and
surrounding tissue, such as the membrane of the intima 32
separating the intima 32 from the media 34, and the adventitia 36.
The membrane or maceration of the intima 32 is a fine, transparent,
colorless structure which is highly elastic, and commonly has a
longitudinal corrugated pattern.
[0060] Adjacent the intima 32 is the media 33, which is the middle
layer of the renal artery 12. The media is made up of smooth muscle
34 and elastic tissue. The media 33 can be readily identified by
its color and by the transverse arrangement of its fibers. More
particularly, the media 33 consists principally of bundles of
smooth muscle fibers 34 arranged in a thin plate-like manner or
lamellae and disposed circularly around the arterial wall 15. The
outermost layer of the renal artery wall 15 is the adventitia 36,
which is made up of connective tissue. The adventitia 36 includes
fibroblast cells 38 that play an important role in wound
healing.
[0061] A perivascular region 37 is shown adjacent and peripheral to
the adventitia 36 of the renal artery wall 15. A renal nerve 14 is
shown proximate the adventitia 36 and passing through a portion of
the perivascular region 37. The renal nerve 14 is shown extending
substantially longitudinally along the outer wall 15 of the renal
artery 12. The main trunk of the renal nerves 14 generally lies in
or on the adventitia 36 of the renal artery 12, often passing
through the perivascular region 37, with certain branches coursing
into the media 33 to enervate the renal artery smooth muscle
34.
[0062] Embodiments of the disclosure may be implemented to provide
varying degrees of denervation therapy to innervated renal
vasculature. For example, embodiments of the disclosure may provide
for control of the extent and relative permanency of renal nerve
impulse transmission interruption achieved by denervation therapy
delivered using a treatment apparatus of the disclosure. The extent
and relative permanency of renal nerve injury may be tailored to
achieve a desired reduction in sympathetic nerve activity
(including a partial or complete block) and to achieve a desired
degree of permanency (including temporary or irreversible
injury).
[0063] Returning to FIGS. 3B and 3C, the portion of the renal nerve
14 shown in FIGS. 3B and 3C includes bundles 14a of nerve fibers
14b each comprising axons or dendrites that originate or terminate
on cell bodies or neurons located in ganglia or on the spinal cord,
or in the brain. Supporting tissue structures 14c of the nerve 14
include the endoneurium (surrounding nerve axon fibers),
perineurium (surrounds fiber groups to form a fascicle), and
epineurium (binds fascicles into nerves), which serve to separate
and support nerve fibers 14b and bundles 14a. In particular, the
endoneurium, also referred to as the endoneurium tube or tubule, is
a layer of delicate connective tissue that encloses the myelin
sheath of a nerve fiber 14b within a fasciculus.
[0064] Major components of a neuron include the soma, which is the
central part of the neuron that includes the nucleus, cellular
extensions called dendrites, and axons, which are cable-like
projections that carry nerve signals. The axon terminal contains
synapses, which are specialized structures where neurotransmitter
chemicals are released in order to communicate with target tissues.
The axons of many neurons of the peripheral nervous system are
sheathed in myelin, which is formed by a type of glial cell known
as Schwann cells. The myelinating Schwann cells are wrapped around
the axon, leaving the axolemma relatively uncovered at regularly
spaced nodes, called nodes of Ranvier. Myelination of axons enables
an especially rapid mode of electrical impulse propagation called
saltation.
[0065] In some embodiments, a treatment apparatus of the disclosure
may be implemented to deliver denervation therapy that causes
transient and reversible injury to renal nerve fibers 14b. In other
embodiments, a treatment apparatus of the disclosure may be
implemented to deliver denervation therapy that causes more severe
injury to renal nerve fibers 14b, which may be reversible if the
therapy is terminated in a timely manner. In preferred embodiments,
a treatment apparatus of the disclosure may be implemented to
deliver denervation therapy that causes severe and irreversible
injury to renal nerve fibers 14b, resulting in permanent cessation
of renal sympathetic nerve activity. For example, a treatment
apparatus may be implemented to deliver a denervation therapy that
disrupts nerve fiber morphology to a degree sufficient to
physically separate the endoneurium tube of the nerve fiber 14b,
which can prevent regeneration and re-innervation processes.
[0066] By way of example, and in accordance with Seddon's
classification as is known in the art, a treatment apparatus of the
disclosure may be implemented to deliver a denervation therapy that
interrupts conduction of nerve impulses along the renal nerve
fibers 14b by imparting damage to the renal nerve fibers 14b
consistent with neruapraxia. Neurapraxia describes nerve damage in
which there is no disruption of the nerve fiber 14b or its sheath.
In this case, there is an interruption in conduction of the nerve
impulse down the nerve fiber, with recovery taking place within
hours to months without true regeneration, as Wallerian
degeneration does not occur. Wallerian degeneration refers to a
process in which the part of the axon separated from the neuron's
cell nucleus degenerates. This process is also known as anterograde
degeneration. Neurapraxia is the mildest form of nerve injury that
may be imparted to renal nerve fibers 14b by use of a treatment
apparatus according to embodiments of the disclosure.
[0067] A treatment apparatus may be implemented to interrupt
conduction of nerve impulses along the renal nerve fibers 14b by
imparting damage to the renal nerve fibers consistent with
axonotmesis. Axonotmesis involves loss of the relative continuity
of the axon of a nerve fiber and its covering of myelin, but
preservation of the connective tissue framework of the nerve fiber.
In this case, the encapsulating support tissue 14c of the nerve
fiber 14b are preserved. Because axonal continuity is lost,
Wallerian degeneration occurs. Recovery from axonotmesis occurs
only through regeneration of the axons, a process requiring time on
the order of several weeks or months. Electrically, the nerve fiber
14b shows rapid and complete degeneration. Regeneration and
re-innervation may occur as long as the endoneural tubes are
intact.
[0068] A treatment apparatus may be implemented to interrupt
conduction of nerve impulses along the renal nerve fibers 14b by
imparting damage to the renal nerve fibers 14b consistent with
neurotmesis. Neurotmesis, according to Seddon's classification, is
the most serious nerve injury in the scheme. In this type of
injury, both the nerve fiber 14b and the nerve sheath are
disrupted. While partial recovery may occur, complete recovery is
not possible. Neurotmesis involves loss of continuity of the axon
and the encapsulating connective tissue 14c, resulting in a
complete loss of autonomic function, in the case of renal nerve
fibers 14b. If the nerve fiber 14b has been completely divided,
axonal regeneration causes a neuroma to form in the proximal
stump.
[0069] A more stratified classification of neurotmesis nerve damage
may be found by reference to the Sunderland System as is known in
the art. The Sunderland System defines five degrees of nerve
damage, the first two of which correspond closely with neurapraxia
and axonotmesis of Seddon's classification. The latter three
Sunderland System classifications describe different levels of
neurotmesis nerve damage.
[0070] The first and second degrees of nerve injury in the
Sunderland system are analogous to Seddon's neurapraxia and
axonotmesis, respectively. Third degree nerve injury, according to
the Sunderland System, involves disruption of the endoneurium, with
the epineurium and perineurium remaining intact. Recovery may range
from poor to complete depending on the degree of intrafascicular
fibrosis. A fourth degree nerve injury involves interruption of all
neural and supporting elements, with the epineurium remaining
intact. The nerve is usually enlarged. Fifth degree nerve injury
involves complete transection of the nerve fiber 14b with loss of
continuity.
[0071] Turning now to FIGS. 4 and 5, there is illustrated computer
modeling of heat distribution through a vessel wall generated by an
RF electrode situated within the lumen of the vessel. In FIG. 4,
the electrode is situated in direct contact with the inner wall of
the vessel. In FIG. 5, the electrode is situated in a
non-contacting (off-wall) relationship with respect to the inner
wall of the vessel in accordance with various embodiments. It is
readily apparent that temperatures of the vessel's inner wall
resulting from the non-contact electrode-to-tissue interface shown
in FIG. 5 are significantly lower than vessel inner wall
temperatures resulting from the direct contact electrode-to-tissue
interface of FIG. 4.
[0072] FIG. 4 shows the heat distribution profile 16 within the
renal artery wall 15 produced by an ablation electrode 92 of a
catheter 90 placed in direct contact with the vessel's inner wall
15a. The catheter 90 includes a conductor 94 that runs the length
of the catheter and is connected to the electrode 92 situated at
the distal end of the catheter 90. In the configuration shown in
FIG. 4, the relative positioning of the electrode 92 and inner wall
15a of the renal artery wall 15 defines a direct contact
electrode-to-tissue interface 91.
[0073] The heat distribution profile 16 of FIG. 4 demonstrates that
the artery wall tissue at or nearest the artery's inner wall 15a is
subject to relatively high temperatures. As can be seen in FIG. 4,
heat produced by the electrode 92 at the direct contact
electrode-to-tissue interface 91 is greatest at the inner wall 15a
and decreases as a function of increasing distance away from the
electrode 92. For example, a heating zone 16a associated with the
highest temperatures produced by the ablation electrode 92 extends
nearly the entire thickness of the artery wall 15. A zone 16b of
lower temperatures relative to zone 16a extends radially outward
from zone 16a, beyond the outer wall 15b of the renal artery 12,
and into perivascular space adjacent the renal artery 12. A
relatively cool zone 16c is shown extending radially outward
relative to zones 16a and 16b. In this simulation, zone 16a is
associated with temperatures required to ablate tissue which
includes renal arterial wall tissue and perivascular renal
nerves.
[0074] FIG. 5 shows the ablation electrode 92 of catheter 90
situated in a spaced-apart relationship relative to the inner wall
15a of the renal artery 12. In the configuration shown in FIG. 5,
the relative positioning of the electrode 92 and inner wall 15a of
the renal artery wall 15 defines a non-contact electrode-to-tissue
interface 93. As can be seen in FIG. 5, the heat distribution
profile 18 differs significantly from that shown in FIG. 4.
[0075] Importantly, zone 18a, which is associated with the highest
temperatures (ablation temperatures), is translated or shifted
outwardly away from the inner wall 15a and towards the outer wall
15b and perivascular space adjacent the renal artery 12. Zone 18a
encompasses an outer portion of the adventitia of the renal artery
wall 15 and encompasses a significant portion of the perivascular
space adjacent the renal artery 12. As such, renal nerves and
ganglia included within the adventitial tissue and perivascular
space are subject to ablative temperatures, while the endothelium
at the inner wall 15a of the renal artery 12 is maintained at a
temperature which does not cause permanent injury to the inner wall
tissue.
[0076] Off-wall electrode configurations according to various
embodiments can reduce the RF current density in the artery wall
15, as the current spreads out somewhat as it passes between the
electrode 102 and the artery wall 15 through the blood. This
provides a sort of fluidic "virtual electrode" and results in less
heating of the artery wall 15 due to the lower current density.
According to various embodiments, structures that hold one or more
electrodes at a prescribed distance away from the artery wall 15
preferably provide for passive cooling of the artery wall 15 during
ablation by blood flowing through the artery 12. Separating the
electrode(s) from the artery wall 15 by a structure that allows
blood to pass along the artery wall 15 provides more effective
cooling of the artery wall 15 (and the electrode 102), further
reducing thermal injury to the artery wall 15. The current density
in the target perivascular tissue can also be somewhat decreased,
but the cooler artery wall temperatures allow greater overall power
to be delivered safely, in order to achieve sufficient current
density in the target tissue to ablate the target tissue.
[0077] Various embodiments of the disclosure are directed to
apparatuses and methods for RF ablation of perivascular renal
nerves for treatment of hypertension, employing one or more bipolar
off-wall RF electrode configurations to more effectively ablate
renal nerves and ganglia near the renal ostium, while avoiding
injury to the renal artery. A bipolar off-wall RF electrode
arrangement of the disclosure includes multiple electrodes held
slightly away from the artery and/or aortal wall, resulting in
decreased current density and improved cooling from the blood to
reduce arterial and/or aortal injury while maintaining target
tissue at ablation temperatures.
[0078] According to some embodiments, an off-wall electrode
arrangement maintains positioning of one or more electrodes at a
separation distance ranging from about 0.5 mm to about 3 mm away
from a vessel wall. According to other embodiments, an off-wall
electrode arrangement maintains positioning of one or more
electrodes at a separation distance ranging from about 1 mm to
about 1.5 mm away from a vessel wall. Prior approaches have used an
RF electrode placed in direct contact with the renal artery, for
example, but have had difficulty in repositioning the electrode to
complete ablation while minimizing injury to the artery wall due to
peak current density and heating at the wall contact points.
[0079] With reference to FIG. 6, a bipolar off-wall RF electrode
arrangement is shown deployed in a patient's renal artery 12 and in
the patient's aorta 20. The bipolar electrode arrangement 40 shown
in FIG. 6 includes an electrode arrangement 50 deployed in the
lumen 13 of the renal artery 12 and an electrode arrangement 60
deployed in the aorta 20 at a location near the aortorenal
junction. Each of the electrode arrangements 50 and 60 includes one
or more RF electrodes which are maintained a predefined distance
away from the renal artery wall and the aortal wall, respectively.
The electrode arrangements 50 and 60 are configured to operate as a
bipolar RF electrode configuration.
[0080] FIG. 7 shows another embodiment of a bipolar off-wall RF
electrode arrangement. In the embodiment illustrated in FIG. 7, the
bipolar electrode arrangement 45 includes an electrode arrangement
55 deployed in the lumen 13a of one of the patient's renal arteries
12a. A second bipolar electrode arrangement 65 is shown deployed in
a lumen 13b of the patient's other renal artery 12b. Each of the
electrode arrangements 55 and 65 includes one or more RF electrodes
which are maintained a predefined distance away from the respective
renal artery walls. The electrode arrangements 50 and 60 are
configured to operate as a bipolar RF electrode configuration.
[0081] It is noted that, in some embodiments, a ground pad may be
used in the configurations shown in FIGS. 6 and 7. For example,
bipolar ablation may be performed using selected electrodes of one
or both of the bipolar electrode arrangements shown in the Figures
and the ground pad. For configurations that include a ground pad,
renal denervation may be selectively performed in a unipolar
ablation mode or a bipolar ablation mode. It is further noted that
the ablation zone is close to the electrode in a unipolar ablation
configuration, but also close to the two electrode arrangements in
a bipolar ablation configuration. Also, it is understood that the
electric field strength decreases as a function of the square of
distance from the electrodes.
[0082] According to various embodiments, and as illustrated in
FIGS. 8 and 9, an RF ablation catheter 100 includes a first
electrode arrangement 102 with at least one and preferably multiple
electrodes 104 mounted on a first expandable structure 101 to
position the electrodes 104 near, but not in direct contact with,
the inner artery wall 15a. Spacing features 106 hold the electrodes
104 a controlled distance from the renal artery wall 15a for
effective wall cooling and to decrease current density at the
artery wall 15a.
[0083] A second electrode arrangement 122 is incorporated into the
same catheter, or into a modified guide catheter or sheath,
similarly positions electrodes 104 near the wall of the aorta 20.
The second electrode arrangement 122 includes at least one and
preferably multiple electrodes 104 mounted on a second expandable
structure 123 to position the electrodes 104 near, but not in
direct contact with, the inner wall of the aorta 20 proximate the
aortorenal junction. Spacing features 106 maintain the electrodes
104 at a controlled distance from the aortal wall for effective
wall cooling and to decrease current density at the aortal
wall.
[0084] Bipolar activation by an external control unit passes RF
energy between aortic and renal artery electrodes 104 of the first
and second the electrode arrangements 102, 122 to preferentially
ablate perivascular tissue near the renal artery ostium where
significant autonomic ganglia are typically located. In some
embodiments, an optional helical actuation wire 110 can be provided
within a lumen of the ablation catheter 100. The helical actuation
wire 110 can be displaced in a distal or proximal direction to
selectively collapse and expand the first and second expandable
structures 101 and 123 of the ablation catheter 100.
[0085] FIG. 9 schematically illustrates RF current passing between
two different pairs of electrodes 104 mounted on the first and
second expandable structures 101, 123, and passing through the
target tissue. Control of which electrodes 104 are energized and in
what combinations and timing is determined automatically by a
control unit which supplies RF energy to the electrodes 104. For
example, selected electrodes 104 of each of the first and second
electrode arrangements 102 can be activated to define or contribute
to different RF current paths. Bifurcated or multiple renal artery
anatomies can be treated with this approach as well. By control of
which electrodes 104 are active, switching between electrodes 104,
and positioning the electrodes 104 away from the vessel walls,
effective heating of the perivascular tissue containing significant
nerves and ganglia is achieved while minimizing thermal injury to
the renal artery 12 and the aorta 20.
[0086] Each electrode 104 in the first electrode arrangement 102
has a corresponding insulated conductor to connect to the external
control unit. The control unit energizes electrodes 104 of the
first and second electrode arrangements 102 and 122 in a prescribed
pattern and sequence. Monitoring of the tissue impedance between
various electrode pairs offers improved evaluation of the extent of
tissue ablation. It is understood that some of the electrodes 104
in the first electrode arrangement 102 can be coupled in series if
desired.
[0087] RF current passes between an electrode 104 in the renal
artery 12 and an electrode 104 in the aorta 20, passing through the
blood for a short distance before passing through the vessel walls
and the intervening tissue. Since blood effectively cools the
vessel wall, the target tissue is ablated without injury to the
vessel walls. An infusion of fluid into the vessel(s) can reduce
the conductivity of the blood to reduce current flow directly
through the blood so that current preferentially passes through
target tissues. A fluid infusion can also reduce effects on the
blood and potential fouling of the electrode surface, allowing
smaller electrodes to be used.
[0088] As is shown in FIGS. 10 and 11, the ablation catheter 100
has a low profile introduction configuration. FIG. 10 shows the
distal end of the ablation catheter 100 in a relatively collapsed
configuration within an external sheath or guide catheter 130. The
flexibility of the first and second electrode arrangement 102 and
122 of the ablation catheter 100 provides for enhanced navigation
and advancement of the catheter 110 through the patient's
vasculature.
[0089] In some embodiments, the first and second expandable
structures 101 and 123 incorporate a shape-memory or a superelastic
member configured to assume desired shapes when in their respective
expanded configurations, such as those shown in FIGS. 8 and 9, for
example. For example, the first and second expandable structures
101 and 123 can each incorporate a shape-memory or a superelastic
helical wire. The helical wire of the first expandable structure
101 has a first diameter when assuming its deployed configuration.
The helical wire of the second expandable structure 123 has a
second diameter when assuming its deployed configuration. As can be
seen in the embodiment illustrated in FIGS. 8 and 9, the second
diameter is greater than the first diameter. In some embodiments,
the second diameter is greater than the first diameter by a factor
of at least 1.5. In other embodiments, the second diameter is
greater than the first diameter by a factor of at least 2.
[0090] Although shown as a continuous unitary member in FIGS. 8 and
9, separate shape-memory or superelastic members may be used for
each of the first and second expandable structures 101 and 123. A
common sheath or separate sheaths may be used to deliver separate
first and second expandable structures 101 and 123 to the renal
artery 12 and aorta 20, respectively.
[0091] A transition region 112 may be defined between the separate
shaping members, and include a material or component that
facilitates independent movement of the separate members during
expansion and collapsing. In some configurations, a continuous
shape-memory or superelastic member can be fashioned with distal
and proximal sections configured to assume desired shapes when in
their respective expanded configurations.
[0092] In FIG. 11, the first electrode arrangement 102 is shown
expanded and deployed in the renal artery 12. The first electrode
arrangement 102 is preferably self-expanding, in that it transforms
from its introduction configuration, shown in FIG. 10, to its
deployed configuration, shown in FIG. 11, when the external sheath
or guide catheter 100 is retracted from the first electrode
arrangement 102. The spacing features 106 keep the electrodes 104 a
short distance away from the artery wall. A variety of spacing
features 106 can be utilized, including bumps or curves, struts or
baskets, spherical or cylindrical elements, and the like. The
spacing features 106 are chosen to minimize interference with blood
flow past the artery wall 15a to maximize the cooling effect on the
artery wall 15a.
[0093] FIG. 11 further shows the second electrode arrangement 122
about to expand as the sheath 130 is retracted. When in its
expanded configuration, the spacing features 106 of the second
electrode arrangement 122 keep the electrodes 104 a short distance
away from the aorta wall 20. The perivascular tissues near the
aortorenal ostium are ablated, including the target renal nerves
and ganglia in that region. After completion of the ablation
procedure, the first and second electrode arrangement 102 and 122
are collapsed, such as by advancing an external sheath 130 over the
arrangements 102, 122. The ablation catheter 100 may be manipulated
to advance the first electrode arrangement 102 into the
contralateral renal artery 12, and the procedure may be
repeated.
[0094] According to some embodiments, the first electrode
arrangement 102 can incorporate a single electrode 104, with a
positioning arrangement configured to hold the electrode 104 near
the center of the renal artery 12. Rather than having the first and
second electrode arrangements 102 and 122 on the same catheter, the
second electrode arrangement 122 can be incorporated into the
external sheath, guide catheter, or other device to provide more
flexibility in positioning electrodes 104 of the second electrode
arrangement 122. Multiple electrodes 104 of the first electrode
arrangement 102 can be energized in parallel, and multiple
electrodes 104 in the second electrode arrangement 122 can be
energized in parallel, in a bipolar arrangement between first and
second electrode arrangements 102 and 122. The second electrode
arrangement 122 can be configured to deploy electrodes 104 at the
opposite side of the aorta 20, or all around the aorta 20.
[0095] In accordance with various embodiments, apparatuses and
methods are directed to bipolar RF ablation of renal autonomic
ganglia and nerves with reduced renal artery injury using dual
ablation catheters. Embodiments according to FIG. 12-14 use
off-wall RF electrodes in each renal artery 12a and 12b to quickly
and effectively ablate renal sympathetic nerves and ganglia without
renal artery injury.
[0096] In the embodiments shown in FIGS. 12-14, a sheath 210 is
shown positioned in the aorta 20 inferior to the aortorenal
junction. It is understood that the sheath 210 may alternatively be
positioned superior to the aortorenal junction. The sheath 210 has
a lumen through which two ablation catheters 220 and 240 are
advanced into respective renal arteries 12a and 12b. According to
some embodiments, the sheath 210 has a diameter of about 6 French
(Fr.) and each of the ablation catheters 220 and 240 has a diameter
of about 3 Fr. In some embodiments, the ablation catheters 220 and
240 are configured as infusion catheters, allowing for imaging
contrast injection into the renal arteries 12a and 12b.
[0097] Each of the ablation catheters 220 and 240 includes an RF
electrode 224 encompassed by a centering basket 226. In a deployed
configuration, as shown in FIG. 12, each centering basket 226
expands radially and makes contact with discrete circumferential
locations of the respective inner renal artery walls. The centering
baskets 226 are configured to position the RF electrode 224
preferably at a center location within the lumens 13a, 13b of the
respective renal arteries 12a, 12b.
[0098] As is shown in FIGS. 12 and 14, a first electrode
arrangement 222a is advanced into one renal artery 12a and a second
electrode arrangement 222b is advanced into the other renal artery
12b. Each centering basket 226 is expanded to hold its respective
electrode 224 a predetermined distance from the renal artery walls
to ensure effective wall cooling from blood flow, and to decrease
current density at the artery walls. It is noted that the first and
second electrode arrangements 222a and 222b may be provided at the
distal portions of a branched catheter, or two small separate
catheters can be used.
[0099] Bipolar activation by an external control unit passes RF
energy between the right and left renal artery electrodes 224 to
preferentially ablate perivascular tissue near the renal artery
ostium where significant autonomic ganglia are typically located.
By positioning the electrodes 224 away from the vessel walls, the
perivascular tissue is effectively heated while minimizing thermal
injury to the renal artery and the aorta. FIG. 12 schematically
illustrates RF current passing between electrodes 224 positioned in
both renal arteries 12a and 12b, and passing through the target
tissue. The control unit automatically controls the energizing of
the electrodes 224. Since more effective heating of a larger amount
of perivascular tissue is obtained without injury to the renal
arteries 12a and 12b, even bifurcated or multiple renal artery
anatomies may be treatable with this approach.
[0100] According to some embodiments, guidewires 221, 241 are
provided to aid in positioning the first and second electrode
arrangements 222a and 222b in the renal arteries 12a and 12b. The
guidewires 221, 241 may have limited freedom to move with respect
to the ablation catheters 220 and 140, so a curved wire tip can be
employed and manipulated as needed to gain access to the renal
arteries 12a and 12b. When configured as infusion catheters,
ablation catheters 220 and 240 can be used for imaging contrast
injection. As can be seen in FIGS. 13a and 13b, the ablation
catheters 220 and 240 have a low profile introduction
configuration. For simplicity of explanation, reference will be
made to ablation catheter 220 in the following discussion,
understanding that the description is equally applicable to
ablation catheter 240. FIG. 13a shows a captured guidewire 221 and
basket stop actuation of a self-collapsing centering basket 226. In
the electrode arrangement 222, the electrode 224 is attached to the
infusion catheter 220 by an insulated strut structure 228, which
also provides for electrical power from the external control unit.
The centering basket 226 is either non-conductive or is
insulated.
[0101] A basket actuation stop 223 is attached to the guidewire
221. After positioning the guidewire 221 as desired and advancing
the ablation catheter 220 to the treatment position, the guidewire
221 and basket actuation stop 223 are retracted to actuate the
centering basket 226 and maintain the basket 226 in a deployed
configuration. The electrode ends can be insulated to avoid current
concentrations near the ends of the electrode 224. After treatment,
the guidewire 221 is advanced to allow the centering basket 226 to
collapse. A sheath 210 (shown in FIG. 12) can be used to further
collapse the centering basket 226 if needed. The centering basket
226 can be preferentially closed according to some embodiments
(e.g., a self-collapsing structure).
[0102] In some embodiments, a somewhat larger basket configuration
can be utilized that is self-expanding (but not necessarily
self-collapsing), such as by use of an external sheath or a pull
wire to collapse the centering basket 226. In other embodiments,
the centering basket 226 need not be biased for self-expansion or
self-collapsing, but may be push-pulled actuated or actuated using
some combination of push, pull, and/or sheath arrangements.
[0103] FIG. 14 shows ablation catheters 222a and 222b in a
collapsed configuration deployed respectively within the patient's
left and right renal arteries 12a and 12b. Access to the lumen 13a
and 13b of the left and right renal arteries 12a and 12b is
facilitated by manipulation of guide wires 221 and 241. Having
accessed the left and right renal arteries 12a and 12b using
guidewires 221 and 241, ablation catheters 220 and 240 are advanced
over their respective guide wires 221 and 241 and into renal
arteries 12a and 12b using an over-the-wire technique. Proper
positioning of the electrode arrangements 222a and 222b may be
facilitated using imaging contrast injection into the ablation
catheters 220a and 220b. In some embodiments, a radiopaque marker
band can be provided at one or more locations of the ablation
catheters 220 and 240 to enhance imaging of catheter positioning.
With the electrode arrangements 222a and 222b positioned at desired
locations within the renal arteries 12a and 12b, the captured
guidewire 221 is pulled in a proximal direction toward the basket
actuation stop 223. As discussed above, retraction of the guidewire
221 forces the centering basket 226 to compress longitudinally and
expand radially into its deployed configuration, as is shown in
FIG. 12.
[0104] An external control unit energizes the electrodes 204 of the
electrode arrangements 222a and 222b in a bipolar manner.
Monitoring of the tissue impedance between the electrodes 204 can
be used for evaluation of the extent of tissue ablation. RF current
passes between the electrodes 204 in the renal arteries 13a and
13b, passing through the blood for a short distance before passing
through the vessel walls and the intervening tissue. Since blood
effectively cools the vessel wall, the target tissue is ablated
without injury to the vessel walls. An infusion of fluid through
the ablation catheters 220 and 240 can locally reduce the
conductivity of the blood to reduce current flow directly through
the blood so that current preferentially passes through target
tissues. As previously discussed, fluid infusion can also reduce
effects on the blood and potential fouling of the electrode
surface, allowing smaller electrodes to be used.
[0105] According to some embodiments, the infusion ablation
catheters 220 and 240 can be D-shaped to maximize infusion space.
Other electrode configurations can be used, including multiple
electrodes in each renal artery. Spacer configurations other than
the illustrated centering basket 226 can be used to keep the
electrodes a minimum distance from the artery walls. One electrode
arrangement can be incorporated into a small infusion catheter
similar to those shown, with the other electrode arrangement
incorporated into an external sheath, guide catheter, or other
device, to provide more flexibility in positioning the ablation
regions or to improve profile or contrast injection capacity. A
separate ground can be provided, such as with conventional skin
ground pads or conductive portions of a guide catheter or sheath.
Instead of or in addition to the bipolar RF configuration as shown,
unipolar configurations with the ablation electrode(s) and the
separate ground can be utilized.
[0106] Turning now to FIGS. 15-18, there is shown an embodiment of
an ablation catheter 320 configured for ablating renal nerves using
a unipolar configuration. Embodiments according to FIGS. 15-18 use
a low profile device with an off-wall RF electrode in the renal
artery to quickly and effectively ablate renal sympathetic nerves
and ganglia without renal artery injury. This approach allows use
of a relatively small (as compared to conventional access
approaches) access sheath to reduce femoral vascular complications,
and can also be used with radial artery access.
[0107] The ablation catheter 320 includes features similar to those
previously described. Because the ablation catheter 320 is
configured for individual deployment as compared to the dual
ablation catheter configurations shown in FIGS. 12-14, somewhat
larger components may be used if desired. For example, and in
accordance with various embodiments, the ablation catheter 320
preferably has a diameter of about 4 Fr. or less, and the delivery
sheath 310 preferably has a diameter of about 4 Fr. or less. The
ablation catheter 320 may be configured as an infusion
catheter.
[0108] An electrode arrangement 322 is shown provided at a distal
end of the ablation catheter 320. The electrode arrangement 322 has
a similar construction and functionality as those previously
described with regard to FIGS. 12-14, and includes an electrode 324
centered within an expandable centering basket 326 and insulated
struts 328. For example, and with reference to FIGS. 17 and 18, the
expandable centering basket 326 can be activated in the manner
described above by retracting a captured guidewire 321 and basket
stop 323 into forced engagement with the centering basket 326.
Expanded views of the electrode arrangement 320 in non-deployed and
deployed configurations are respectively shown in FIGS. 16A and
16B.
[0109] For example, apparatuses in accordance with various
embodiments include a small infusion catheter 320 with an ablation
region 322 near the distal end of the catheter 320. The ablation
region 322 has an RF electrode 224 and a centering basket 326. The
ablation region 322 is advanced from either a superior (see FIGS.
17 and 18) or an inferior (see FIG. 15) aortal location into the
renal artery 12. The centering basket 322 is expanded to hold the
electrode 324 a minimum distance from the renal artery wall to
guarantee effective wall cooling from blood flow, and to decrease
current density at the artery wall. RF energy provided by an
external control unit is passed between the electrode 324 and a
ground pad to preferentially ablate perivascular tissue where the
target autonomic nerves are located. By positioning the electrode
324 away from the vessel walls, the perivascular tissue is
effectively heated while minimizing thermal injury to the renal
artery.
[0110] A guidewire 321 is provided to aid in positioning the
ablation region 322 in the renal artery 12. The guidewire 321 may
have limited freedom to move with respect to the ablation catheter
320, so a curved wire tip can be manipulated as needed to gain
access to the renal artery 12. The ablation catheter 320 may be
configured as an infusion catheter, and can be used for imaging
contrast injection.
[0111] In the embodiments according to FIGS. 15-18, an external
control unit is used to energize the electrode 324 in a controlled
manner. Monitoring of the tissue impedance can be used for
evaluation of the extent of tissue ablation. RF current passes
between the electrode 324 and the ground (such as an external
ground pad), passing through the blood for a short distance before
passing through the vessel walls and the perivascular tissue. Since
blood effectively cools the vessel wall, the target tissue is
ablated without injury to the vessel walls. An infusion of fluid
through the ablation catheter 320 can locally reduce the
conductivity of the blood to reduce current flow directly through
the blood so that current preferentially passes through target
tissues. A fluid infusion will also reduce effects on the blood and
potential fouling of the electrode surface, allowing a smaller
electrode to be used.
[0112] After ablating renal arterial tissue in the one renal
artery, the guidewire 321 is advanced to allow the centering basket
326 to collapse, and the apparatus is repositioned in the
contralateral renal artery for treatment. The sheath 310 can be
used to further collapse the centering basket 326 if needed. The
centering basket 326 can be preferentially closed
("self-collapsing"). Since more effective heating of a larger
amount of perivascular tissue is obtained without injury to the
renal artery, even bifurcated or multiple renal artery anatomies
may be treatable with this approach.
[0113] Various embodiments provide for a reduce profile
configuration by using a captured guidewire 321. Alternatively, a
standard guidewire can be used, by adding an actuation filament or
sleeve, with slightly larger profile. For example, a non-conductive
filament can pull back on the centering basket stop 323 to deploy
the centering basket 326. In other embodiments, a self-expanding
basket 326 can be used, and an outer sheath 310 is added. The outer
sheath 310 is advanced over the centering basket 326 for
low-profile introduction, and is retracted to allow the basket 326
to expand. Other electrode configurations can be used, including
multiple electrodes 324 and centering baskets 326 in each renal
artery. Spacer configurations other than the illustrated centering
basket 326 can be used to keep the electrodes 324 a minimum
distance from the artery walls. Instead of a monopolar
configuration with a separate ground pad, the ground can be
conductive portions of a guide catheter or sheath, or multiple
electrodes 324 can be used in a bipolar configuration.
[0114] FIG. 19 shows a representative RF renal therapy apparatus
400 in accordance with various embodiments of the disclosure. The
apparatus 400 illustrated in FIG. 19 includes external electrode
activation circuitry 420 which comprises power control circuitry
422 and timing control circuitry 424. The external electrode
activation circuitry 420, which includes an RF generator, is
coupled to temperature measuring circuitry 428 and may be coupled
to an optional impedance sensor 426. An ablation catheter 402
includes a shaft 404 that incorporates a lumen arrangement 405
configured for receiving a variety of components, such as
conductors, pharmacological agents, actuator elements, obturators,
sensors, or other components as needed or desired. A delivery
sheath 403 may be used to facilitate deployment of the catheter 402
into the arterial system via a percutaneous access site 406 in the
embodiment shown in FIG. 19. The distal end of the catheter 402 may
include a hinge mechanism 456 to facilitate navigation of the
catheter's distal tip around turn of approximately 90.degree. from
the aorta to a renal artery 12. The RF generator of the external
electrode activation circuitry 420 may include a pad electrode 430
that is configured to comfortably engage the patient's back or
other portion of the body near the kidneys. Radiofrequency energy
produced by the RF generator is coupled to the flexible electrode
arrangement 100 at the distal end of the ablation catheter 402 by
the conductor arrangement disposed in the lumen of the catheter's
shaft 404.
[0115] Renal denervation therapy using the apparatus shown in FIG.
19 can be performed in a unipolar or monopolar mode using the
flexible electrode arrangement 100 positioned within the renal
artery 12 and the pad electrode 430 positioned on the patient's
back, with the RF generator operating in a monopolar mode. In other
implementations, multiple flexible electrode arrangements, such as
those shown in previous figures, can be configured for operation in
a bipolar configuration, in which case the electrode pad 330 is not
needed. Representative bipolar configurations include a pair of
flexible electrode arrangements, one in each of the patient's renal
arteries. Other representative bipolar configurations include one
flexible electrode arrangement positioned in one renal artery and
another flexible electrode arrangement positioned in the aorta
proximate the aortorenal junction. The radiofrequency energy flows
through the flexible electrode arrangement or multiple arrangements
in accordance with a predetermined activation sequence (e.g.,
sequential or concurrent) and into the adjacent tissue of the renal
artery. In general, when renal artery or aortal tissue temperatures
rise above about 113.degree. F. (50.degree. C.), protein is
permanently damaged (including those of renal nerve fibers). If
heated over about 65.degree. C. and up to 100.degree. C., cell
walls break and oil separates from water. Above about 100.degree.
C., tissue desiccates.
[0116] According to some embodiments, the electrode activation
circuitry 420 is configured to control activation and deactivation
of one or more electrodes of the flexible electrode arrangement(s)
in accordance with a predetermined energy delivery protocol and in
response to signals received from temperature measuring circuitry
428. The electrode activation circuitry 420 controls radiofrequency
energy delivered to the electrodes of the flexible electrode
arrangement(s) so as to maintain the current densities at a level
sufficient to cause heating of the target tissue preferably to a
temperature of at least about 55.degree. C.
[0117] In some embodiments, one or more temperature sensors are
situated at the flexible electrode arrangement(s) and provide for
continuous monitoring of renal artery tissue temperatures, and RF
generator power is automatically adjusted so that the target
temperatures are achieved and maintained. An impedance sensor
arrangement 426 may be used to measure and monitor electrical
impedance during RF denervation therapy, and the power and timing
of the RF generator 420 may be moderated based on the impedance
measurements or a combination of impedance and temperature
measurements. The size of the ablated area is determined largely by
the size, shape, number, and arrangement of the electrodes
supported by the flexible electrode arrangement(s), the power
applied, and the duration of time the energy is applied.
[0118] With reference to FIG. 20, there is shown an embodiment of
an ablation catheter 520 configured for ablating renal nerves using
either a unipolar configuration or a bipolar configuration. In the
embodiment shown in FIG. 20, an electrode arrangement 522 is
provided at a distal end of the catheter 520 and is encompassed by
a spacing basket 529. The spacing basket 529, unlike the centering
basket implementations discussed previously, is dimensioned to be
smaller than the diameter of the lumen 13 of the renal artery 12.
In this configuration, the electrode 524 is preferably positioned
at an off-center location within the lumen 13 and biased against an
inner wall portion of the renal artery 12.
[0119] In use, the ablation catheter 520 is advanced into the renal
artery 12 via a delivery sheath 521. When positioned at a desired
location within the renal artery 12, the spacing basket 529 is
expanded to hold the electrode 524 a desired distance from the
renal artery wall, such as between about 0.5 and 1.0 mm away from
the renal artery wall. A biasing force produced by the shaft of the
catheter 520, which can be augmented by adjusting the position of
delivery sheath 521 relative to the catheter's shaft, maintains the
expanded spacing basket 529 and electrode 524 in proper position
during ablation. The spacing basket 529 can be moved
circumferentially about the inner wall of the renal artery 12 to
create a circumferential lesion with reduced injury to the renal
artery's inner wall. The spacing basket 529, although biased
against the wall of the renal artery 12, maintains the electrode
524 at a predefined distance from the artery wall during ablation,
which provides effective cooling from blood flow and decreases
current density at the artery wall. Biasing, bending, or deflection
structures can be provided to bias the spacing basket 529 toward
the artery wall as desired. Various aspects of a centered
larger-basket device as shown in the figures can be applied to the
non-centered smaller basket configurations.
[0120] FIG. 21 shows an embodiment of an ablation catheter 620
deployed within the lumen 13 of a patient's renal artery 12. In
this embodiment, the ablation catheter 620 includes a centering
basket 629 which encompasses an ultrasound ablation device 624. The
centering basket 629 is preferably configured in a manner
previously described. The ultrasound ablation device 624 preferably
includes one or more cylindrical ultrasound transducers which can
focus acoustic energy at target tissue and at desired depths within
and beyond (e.g., perivascular space) the wall of the renal artery
12. In some embodiments, the ultrasound ablation device 624 can
operate at cooler temperatures than RF ablation electrodes due to
its ability to focus acoustic energy efficiently at target tissue,
which reduces the risk of injury to the inner wall of the renal
artery 12.
[0121] Representative examples of ultrasound transducers configured
for renal denervation are disclosed in commonly owned co-pending
U.S. patent application Ser. No. 13/086,116, which is incorporated
herein by reference. For example, ultrasound ablation device 624
can be configured as a multiple element intraluminal ultrasound
cylindrical phased array, with a multiplicity of ultrasound
transducers distributed around the periphery of a cylindrical
member. The ultrasound ablation device 624 may be used for imaging
and ablation when operated in an imaging mode and an ablation mode,
respectively. In some embodiments, renal ablation using the
ultrasound ablation device 624 may be conducted under magnetic
resonance imaging guidance.
[0122] Various embodiments disclosed herein are generally described
in the context of ablation of perivascular renal nerves for control
of hypertension. It is understood, however, that embodiments of the
disclosure have applicability in other contexts, such as performing
ablation from within other vessels of the body, including other
arteries, veins, and vasculature (e.g., cardiac and urinary
vasculature and vessels), and other tissues of the body, including
various organs.
[0123] It is to be understood that even though numerous
characteristics of various embodiments have been set forth in the
foregoing description, together with details of the structure and
function of various embodiments, this detailed description is
illustrative only, and changes may be made in detail, especially in
matters of structure and arrangements of parts illustrated by the
various embodiments to the full extent indicated by the broad
general meaning of the terms in which the appended claims are
expressed.
* * * * *